New Brain Imaging Technique Uncovers Hidden Vascular Changes with Age

Researchers at the Keck School of Medicine of USC have developed an innovative brain imaging method that provides new insights into how tiny blood vessels in the brain pulse with each heartbeat—a process that changes with age and may have implications for neurodegenerative diseases such as Alzheimer's. Published in Nature Cardiovascular Research, this pioneering noninvasive technique measures 'microvascular volumetric pulsatility,' capturing the rhythmic expansions and contractions of the brain’s smallest vessels in living humans.

Using ultra-high-field 7 Tesla MRI, the team demonstrated that microvessels exhibit increased pulsations as people age, particularly in the deep white matter regions. These areas are instrumental in connecting brain networks but are especially vulnerable to reduced blood flow from arteries that carry blood away from the heart. Excessive pulsations in these tiny vessels could disrupt brain functions, potentially accelerating memory decline and related disorders.

"Arterial pulsation functions like a natural pump, assisting fluid movement and waste clearance," explained Dr. Danny JJ Wang. "Our method allows us to observe how these vessel volumes change with age and vascular health, opening new avenues for studying brain health, dementia, and small vessel disease."

Traditionally, measuring pulsations in the brain’s smallest vessels posed significant challenges without invasive procedures used mainly in animal studies. However, this new approach combines advanced MRI techniques—vascular space occupancy (VASO) and arterial spin labeling (ASL)—to detect subtle volume fluctuations throughout the cardiac cycle. The findings confirm that older adults experience heightened pulsations in deep white matter, intensified by conditions like hypertension.

This research links microvascular health to larger vessel function and suggests that increased pulsatility may impair the brain's glymphatic system, which helps clear waste products like beta-amyloid—proteins associated with Alzheimer’s pathology. Over time, disrupted waste removal could contribute to cognitive decline.

Lead researcher Dr. Fanhua Guo emphasized the significance of in vivo measurement capabilities and mentioned ongoing efforts to adapt this technology for more accessible clinical settings, including 3 Tesla MRI scanners. Future studies aim to determine whether microvascular pulsatility can serve as an early biomarker for neurodegenerative diseases, guiding intervention and prevention strategies.

This breakthrough not only advances understanding of brain aging but also offers potential for earlier diagnosis and targeted treatments of neurovascular and neurodegenerative conditions, affecting millions worldwide.